These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Changes in general hemostasis in patients with diabetic retinopathy]. Evgrafov VIu; Markova OA; Grishin VL; Efimov VS Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770 [TBL] [Abstract][Full Text] [Related]
4. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852 [TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor in diabetic retinopathy. Abayomi EA; Miller E; Paton RC Cent Afr J Med; 1996 Jul; 42(7):205-6. PubMed ID: 8936786 [TBL] [Abstract][Full Text] [Related]
6. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor, diabetes mellitus and retinopathy. Paton RC; Passa P; Canivet J Horm Metab Res Suppl; 1981; 11():55-8. PubMed ID: 6797913 [TBL] [Abstract][Full Text] [Related]
8. Inflammation, endothelium, and coagulation in sepsis. Schouten M; Wiersinga WJ; Levi M; van der Poll T J Leukoc Biol; 2008 Mar; 83(3):536-45. PubMed ID: 18032692 [TBL] [Abstract][Full Text] [Related]
9. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus. Blann AD; Lip GY Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464 [TBL] [Abstract][Full Text] [Related]
10. [Behavior of factor VIII in diabetes mellitus in relation to diabetic retinopathy]. Miralles García JM; De Pablo Dávila F; Sánchez Martin S; Alberca Silva I Rev Clin Esp; 1980 Feb; 156(3):193-6. PubMed ID: 6966066 [No Abstract] [Full Text] [Related]
11. [Progress of research on pathogenesis and medical treatment of diabetic retinopathy]. Geng S; Ye JJ Zhonghua Yan Ke Za Zhi; 2008 Jan; 44(1):76-81. PubMed ID: 18510248 [TBL] [Abstract][Full Text] [Related]
12. Platelet abnormalities as related to diabetic retinopathy (with special reference to platelet shape change). Porta M; O'Brien ME; Kohner EM Horm Metab Res Suppl; 1981; 11():50-4. PubMed ID: 6797912 [TBL] [Abstract][Full Text] [Related]
13. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume. Rao AK; Goldberg RE; Walsh PN J Lab Clin Med; 1984 Jan; 103(1):82-92. PubMed ID: 6690642 [TBL] [Abstract][Full Text] [Related]
14. [Change in the blood coagulating and fibrinolytic systems in diabetic retinopathy and its treatment with anticoagulant and fibrinolytic preparations]. Mikhaĭlova NA; Tartakovskaia AI Vestn Oftalmol; 1972; 5():88-91. PubMed ID: 4667907 [No Abstract] [Full Text] [Related]
15. [Recent advances in the studies of genetic polymorphisms in diabetic retinopathy]. Wang N; Xu X Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):563-6. PubMed ID: 16857146 [TBL] [Abstract][Full Text] [Related]
18. Endothelium dysfunction markers in patients with diabetic retinopathy. Siemianowicz K; Francuz T; Gminski J; Telega A; Syzdól M Int J Mol Med; 2005 Mar; 15(3):459-62. PubMed ID: 15702238 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy]. Slepova OS; Gerasimenko VL; Zakharova GIu; Novikova-Bilak TI Vestn Oftalmol; 2001; 117(3):35-7. PubMed ID: 11521435 [TBL] [Abstract][Full Text] [Related]